Home / Blog / NF1 Optic Pathway Gliomas Study
Identify biomarkers for visual restoration strategies in Neurofibromatosis Type 1 optic pathway glioma patients.
Stanford Ophthalmology, Children’s Hospital of Philadelphia and Gilbert Family Foundation | 2024
This study is seeking to learn how different eye tests and devices can help understand vision in patients with NF1, including how vision loss might show up on different eye imaging devices that measure the nerves or the blood vessels of the eye. The study aims to understand the mechanisms of vision loss caused by neurofibromatosis type 1 (NF1)-associated optic pathway gliomas, or NF1-OPGs. Subjects eight years and older with NF1 are eligible to enroll.
Recent Posts
-
Behind every clinical trial is a team that keeps it running day to day. For 45 years, NF Midwest has supported research into the many complications of NF1, NF2-related schwannomatosis, and other forms of schwannomatosis. Today, that investment is paying off close to home. NF clinical trials are happening right here in the Midwest, and...
Read More
-
Offered by: University of Colorado AnschutzConducted by: Katelyn Glowinski, genetic counseling student, master’s program This research study is designed to gain a better understanding of healthcare barriers faced by adults with Neurofibromatosis Type 1 (NF1), as well as evaluate any associations between these barriers and your self-reported neuropsychiatric or mental health status. If you join...
Read More
Responses